These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
497 related items for PubMed ID: 21176332
1. SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update. Reid R, CLINICAL PRACTICE GYNAECOLOGY COMMITTEE. J Obstet Gynaecol Can; 2010 Dec; 32(12):1192-1197. PubMed ID: 21176332 [Abstract] [Full Text] [Related]
2. SOGC clinical practice guidelines: Oral contraceptives and the risk of venous thromboembolism: an update: no. 252, December 2010. Reid R, Leyland N, Wolfman W, Allaire C, Awadalla A, Best C, Dunn S, Lemyre M, Marcoux V, Menard C, Potestio F, Rittenberg D, Singh S, Senikas V, Society of Obstetricians and Gynaecologists of Canada. Int J Gynaecol Obstet; 2011 Mar; 112(3):252-6. PubMed ID: 21416656 [Abstract] [Full Text] [Related]
3. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception. Black A, Guilbert E, Costescu D, Dunn S, Fisher W, Kives S, Mirosh M, Norman W, Pymar H, Reid R, Roy G, Varto H, Waddington A, Wagner MS, Whelan AM, Mansouri S. J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746 [Abstract] [Full Text] [Related]
4. Canadian Contraception Consensus (Part 2 of 4). Black A, Guilbert E, Co-Authors, Costescu D, Dunn S, Fisher W, Kives S, Mirosh M, Norman WV, Pymar H, Reid R, Roy G, Varto H, Waddington A, Wagner MS, Whelan AM, Special Contributors, Ferguson C, Fortin C, Kielly M, Mansouri S, Todd N. J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725 [Abstract] [Full Text] [Related]
5. Canadian Contraception Consensus (Part 1 of 4). Black A, Guilbert E, Co-Authors, Costescu D, Dunn S, Fisher W, Kives S, Mirosh M, Norman WV, Pymar H, Reid R, Roy G, Varto H, Waddington A, Wagner MS, Whelan AM, Special Contributors, Ferguson C, Fortin C, Kielly M, Mansouri S, Todd N, Society of Obstetricians and Gynaecologists of Canada. J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712 [Abstract] [Full Text] [Related]
6. Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective. Raymond EG, Burke AE, Espey E. Obstet Gynecol; 2012 May; 119(5):1039-44. PubMed ID: 22525916 [Abstract] [Full Text] [Related]
7. Hormonal contraceptives and venous thromboembolism: an epidemiological update. Plu-Bureau G, Maitrot-Mantelet L, Hugon-Rodin J, Canonico M. Best Pract Res Clin Endocrinol Metab; 2013 Feb; 27(1):25-34. PubMed ID: 23384743 [Abstract] [Full Text] [Related]
8. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study. Dinger J, Assmann A, Möhner S, Minh TD. J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364 [Abstract] [Full Text] [Related]
9. [Venous thromboembolism in adolescents associated with fourth-generation oral contraceptives]. Botzenhardt S, Toni I, Rascher W, Neubert A. Klin Padiatr; 2013 Sep; 225(5):268-76. PubMed ID: 23979828 [Abstract] [Full Text] [Related]
10. Epidemiology of hormonal contraceptives-related venous thromboembolism. Hugon-Rodin J, Gompel A, Plu-Bureau G. Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200 [Abstract] [Full Text] [Related]
11. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products. Sehovic N, Smith KP. Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756 [Abstract] [Full Text] [Related]
13. Pregnancy outcomes after assisted human reproduction. Okun N, Sierra S, GENETICS COMMITTEE, SPECIAL CONTRIBUTORS. J Obstet Gynaecol Can; 2014 Jan; 36(1):64-83. PubMed ID: 24444289 [Abstract] [Full Text] [Related]
14. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. Lidegaard Ø, Nielsen LH, Skovlund CW, Skjeldestad FE, Løkkegaard E. BMJ; 2011 Oct 25; 343():d6423. PubMed ID: 22027398 [Abstract] [Full Text] [Related]
15. ACOG Committee Opinion Number 540: Risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills. Committee on Gynecologic Practice. Obstet Gynecol; 2012 Nov 25; 120(5):1239-42. PubMed ID: 23090561 [Abstract] [Full Text] [Related]
16. Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception. Ramanadhan S, Hansen K, Henderson JT, Cohen MA, Paynter R, Edelman A. Cochrane Database Syst Rev; 2023 May 15; 5(5):CD014908. PubMed ID: 37184292 [Abstract] [Full Text] [Related]
17. Canadian Contraception Consensus (Part 3 of 4): Chapter 8 - Progestin-Only Contraception. Black A, Guilbert E, Costescu D, Dunn S, Fisher W, Kives S, Mirosh M, Norman W, Pymar H, Reid R, Roy G, Varto H, Waddington A, Wagner MS, Whelan AM. J Obstet Gynaecol Can; 2016 Mar 15; 38(3):279-300. PubMed ID: 27106200 [Abstract] [Full Text] [Related]
18. Does the Progestogen Used in Combined Hormonal Contraception Affect Venous Thrombosis Risk? Han L, Jensen JT. Obstet Gynecol Clin North Am; 2015 Dec 15; 42(4):683-98. PubMed ID: 26598309 [Abstract] [Full Text] [Related]
19. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data. Jick SS, Hernandez RK. BMJ; 2011 Apr 21; 342():d2151. PubMed ID: 21511805 [Abstract] [Full Text] [Related]